Nicholas J. Brandon, MA, PhD

Nick Brandon PhD is the Chief Scientific Officer of Neumora, a biotechnology company he helped to found in 2019, focused on understanding the complexities of brain disorders and seeking to take a Precision Neuroscience drug development approach to treat them. After completing a PhD and postdoctoral studies in the UK he has spent his career working in pharmaceutical or biotechnology companies with the goal of delivering new medicines for disorders of the brain. This includes periods at Merck, Wyeth, Pfizer, AstraZeneca and more recently at Neumora, He has successfully delivered multiple molecules to ‘Development candidate status’ and ‘IND’ principally in the areas of neuropsychiatry and neurodegeneration research. In addition Nick has led basic research laboratories which have made fundamental discoveries around drug targets and much of these was accomplished with collaborations with academic partners including with the Wade-Martins lab in Oxford (Supported by a grant from MJFF). Since 2020 Nick has worked closely with the Neumora team named on this MJFF proposal on multiple programs including the identification of selective GCase activators for Parkinson's disease.